FLC fluence corporation limited

4.88%

3.9¢

Fluence Signs First Commercial SUBRE Order in China, page-5

First 5 Last

Share
Profile

Follow
ywtoh

1,933 Posts.

2163

19/08/19

16:45

Post #: 40043182
Share

Originally posted by stockrock: ↑

The first SUBRE order in China was always going to be the hardest to sign up ... but they finally got it with Panjin City.

For Fluence to achieve its growth ambitions in FY20 and beyond, it was critical to get a SUBRE reference site in China. It is only a matter of time before other governments follow. In fact any water treatment facility looking to be commissioned going forward (or upgrade) should be looking to have SUBRE installed.

In terms of magnitude, today's order was on the lower end of what SUBRE is able to achieve. SUBRE installations are for treatment plants ranging from 2,000 - 100,000 m³ a day. Today's falls into the lower end with 3,000 m³being treated at Panjin City, but should still gross in excess of US$1m at 50% margin.

For context, the first two greenfield installations announced in Mar19 (Jamaica) were for 12 and 6 SUBRE units (or 54 MABR modules). Today's is for 28 SUBRE units, or 84 MABR modules. So whilst it is on the lower end, it is still larger than the first two order combined.

More importantly it demonstrates Fluence's versatility and ability to leverage its technical expertise across product ranges. Having SUBRE operate in -20 degrees is very impressive and opens up the northern part of China and colder climate countries around the world.

The US$1m+ should bring SPS YTD sales to approx US$7m, with US$26m in SPS sales the target for FY19. This means a further US$19m in SPS sales to be announced by years end...

Expand

Thank you @stockrock for your views. I cannot add any more weight to your views unless I turn blue in the face. But I just hope newbies will heed your wise analysis, sit up and take notice. This is as major a breakthrough for me as the iTest win because the retrofit market that SUBRE addresses is a hundred times larger than the rural segment that Aspiral is addressing. The price is muted in its response, and that is ok. But for me, it's more important to me the company continues to derisk. Well done to FLC's China team.

FLC Price at posting: 43.0¢ Sentiment: Buy Disclosure: Held
33 Upvote

9 Great analysis

Reply

Top Stories

'Not possible' to port renewable gas: ACCC takes AGN to court

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

BOE

Boss extends June win streak with boosted Alta Mesa extraction rates

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

First 5 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 3.9¢		Change -0.002(4.88%)		Mkt cap ! $42.32M

Open	High	Low	Value	Volume
4.1¢	4.1¢	3.8¢	$17.54K	451.2K

Buyers (Bids)

No.	Vol.	Price($)
1	6812	3.9¢

Sellers (Offers)

Price($)	Vol.	No.
4.2¢	161616	4

View Market Depth

No.	Vol.	Price($)
1	6812	0.039
1	13250	0.038
2	370000	0.037
1	350000	0.036
2	220000	0.035

Price($)	Vol.	No.
0.042	161616	4
0.043	120000	1
0.045	25000	1
0.047	2224	1
0.050	67600	1

Last trade - 15.51pm 27/06/2025 (20 minute delay)

FLC (ASX) Chart

Fluence Signs First Commercial SUBRE Order in China, page-5

'Not possible' to port renewable gas: ACCC takes AGN to court

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

Boss extends June win streak with boosted Alta Mesa extraction rates

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

Australia’s gas crisis is here – and dying coal plants aren’t helping

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Fluence Signs First Commercial SUBRE Order in China, page-5

Top Stories

'Not possible' to port renewable gas: ACCC takes AGN to court

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

Boss extends June win streak with boosted Alta Mesa extraction rates

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

Australia’s gas crisis is here – and dying coal plants aren’t helping

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News